<\/p>\n
One of the founding directors of Dis-Chem, Stanley Goetsch, will step down as an executive on 30 June. This coincides with one of the pharmacy group\u2019s co-founders, Ivan Saltzman, also vacating his executive role.<\/p>\n
Saltzman, who was CEO until June 2023, will remain on the board as a non-executive director and deputy chairman.<\/p>\n
Once Goetsch and Saltzman depart, there will be no founding directors remaining in executive roles.<\/p>\n
Lynette Saltzman, the other co-founder of the business alongside her husband in 1978, resigned from her executive role in July 2022 to \u201cdirect her focus on her operational role within the beauty category\u201d.<\/p>\n
Read:\u00a0Dis-Chem founder gifts R6.8bn stake to sons<\/p>\n
Saul, one of the Saltzmans\u2019 three sons who had been in the business since 2005, resigned as an executive in October, effective the end of February 2026. He remains a non-independent non-executive director on the board.<\/p>\n
ADVERTISEMENT<\/p>\n
CONTINUE READING BELOW<\/p>\n<\/div>\n<\/div>\n
Goetsch had been with the group for 42 years with an additional year\u2019s experience in the industry elsewhere. Prior to being appointed category executive at Dis-Chem, he served as a pharmacist and store manager.<\/p>\n
Read\/Listen:
Dis-Chem sees earnings lifted by once-off property boost, hikes dividend
Dis-Chem set for stronger full-year performance<\/p>\n
Prior to its listing in November 2016, Goetsch \u2013 through Stansh (Pty) Ltd \u2013 owned 10.4% of the group. His interest was not disclosed for a number of years following the listing, but in 2020 the group shared that he held an interest of 50 million shares in the group indirectly. This equated to 5.8%.<\/p>\n
\nSince then, Goetsch has steadily been reducing the stake. At the end of the 2025 financial year (ended 28 February), he held 29.9 million shares, equating to 3.5% of the group.<\/p>\n<\/blockquote>\n
At that point, his holding was valued at around R1 billion. In FY2025, Goetsch sold three tranches of shares for a total of R170 million. He has sold additional shares during FY26 for a further R84 million.<\/p>\n
\n\n
\n Goetsch share sales FY26<\/td>\n Number of shares<\/td>\n Value<\/td>\n<\/tr>\n \n 1 July 2025*<\/td>\n 38 565<\/td>\n R1\u00a0250 671<\/td>\n<\/tr>\n \n 16 January 2026<\/td>\n 1\u00a0000 000<\/td>\n R36\u00a0000 000<\/td>\n<\/tr>\n \n 22 January 2026<\/td>\n 300 000<\/td>\n R10\u00a0860 360<\/td>\n<\/tr>\n \n 22 January 2026<\/td>\n 674 129<\/td>\n R24\u00a0538 296<\/td>\n<\/tr>\n \n 20 February 2026<\/td>\n 294 231<\/td>\n R11\u00a0181 013<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n * Part of a group of transactions for all executive directors where shares awarded in terms of the group\u2019s forfeitable share plan vested and were disposed<\/em><\/p>\n
Along with these sales by Goetsch, the Saltzmans have also been reducing their holding in the group over time. In June 2025, they gifted a 25% stake in the business, valued at R6.8 billion, to their two other sons, Dan and Mark.<\/p>\n
\n\nADVERTISEMENT:<\/p>\n
CONTINUE READING BELOW<\/p>\n<\/div>\n<\/div>\n
The total of 217 million Dis-Chem shares were previously held by Ivlyn Local Investment Holdings, a vehicle of the founders.<\/p>\n
Read:\u00a0Saltzman sons sell R640m in Dis-Chem shares<\/p>\n
At the time, it said Saltzman [Ivan] is \u201cin the process of restructuring his interest in the Dis-Chem share portfolio which is held through Ivlyn Local Investment Holdings Proprietary Limited \u2026 All distributed shares will remain within the Saltzman family, thereby continuing current family ownership.\u201d<\/p>\n
This distribution was the bulk of their holding of 252 million shares in the group. Following the \u2018gifting\u2019, the founders owned just 4.06% of the company.<\/p>\n
The sons have subsequently, through January and February 2026, sold a total of R640 million of shares in Dis-Chem. Both are believed to have emigrated.<\/p>\n<\/p><\/div>\n